These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6352601)

  • 1. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
    Reed WP; Palmer DL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
    Vestin L; Burman LA; Holm S; Sellers J
    Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
    J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trail.
    Ramírez-Ronda CH; Gutiérrez J; Bermúdez RH
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():125-9. PubMed ID: 6210660
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    Am J Med; 1985 Nov; 79(5B):88-90. PubMed ID: 4073101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa.
    Gonzalez MA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
    del Rosal PL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
    Schaad UB; Desgrandchamps D; Kraemer R
    Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections.
    Madsen PO; Nielsen OS
    Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
    Bauernfeind A; Petermüller C; Dietzel M
    Infection; 1979; 7(1):21-6. PubMed ID: 422252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Scand J Infect Dis Suppl; 1981; 29():98-101. PubMed ID: 6947409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.